These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29067667)

  • 21. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
    J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript.
    Todeschini A; Gualandi F; Trabanelli C; Armaroli A; Ravani A; Fanin M; Rota S; Bello L; Ferlini A; Pegoraro E; Padovani A; Filosto M
    Neuromuscul Disord; 2016 Oct; 26(10):662-665. PubMed ID: 27616544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.
    Berger J; Berger S; Hall TE; Lieschke GJ; Currie PD
    Neuromuscul Disord; 2010 Dec; 20(12):826-32. PubMed ID: 20850317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
    Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
    Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dystrophin Protein Quantification as a Duchenne Muscular Dystrophy Diagnostic Biomarker in Dried Blood Spots Using Multiple Reaction Monitoring Tandem Mass Spectrometry: A Preliminary Study.
    Nimer RM; Sumaily KM; Almuslat A; Abdel Jabar M; Sabi EM; Al-Muhaizea MA; Abdel Rahman AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Duchenne muscular dystrophy: rational basis, state of the art].
    Palmieri B; Sblendorio V
    Recenti Prog Med; 2006 Sep; 97(9):441-7. PubMed ID: 17017293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
    Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of degeneration and regeneration in Duchenne muscular dystrophy.
    Abdel-Salam E; Abdel-Meguid I; Korraa SS
    Acta Myol; 2009 Dec; 28(3):94-100. PubMed ID: 20476668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions.
    Takeshita E; Minami N; Minami K; Suzuki M; Awashima T; Ishiyama A; Komaki H; Nishino I; Sasaki M
    Neuromuscul Disord; 2017 Jun; 27(6):569-573. PubMed ID: 28434908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver.
    Hughes MS; Marsh JN; Wallace KD; Donahue TA; Connolly AM; Lanza GM; Wickline SA
    Ultrasound Med Biol; 2007 Aug; 33(8):1236-43. PubMed ID: 17467153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin.
    Zatz M; Pavanello RC; Lazar M; Yamamoto GL; Lourenço NC; Cerqueira A; Nogueira L; Vainzof M
    Neuromuscul Disord; 2014 Nov; 24(11):986-9. PubMed ID: 25047667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.